This document provides details on contouring and delineating target volumes for breast cancer radiation therapy. It discusses the anatomy and boundaries of lymph node regions in the supraclavicular, axillary, internal mammary, and mediastinal areas. Diagrams show the relationships between surrounding structures like blood vessels, muscles, bones, and organs. Guidelines are provided for accurately defining clinical target volumes on different imaging planes and slices.
This document discusses various radiotherapy techniques used for breast cancer treatment planning and delivery. It covers topics like positioning, immobilization, target volume delineation, treatment planning, dose prescription, and techniques to minimize doses to organs at risk. Some key points include the use of breast boards and immobilization devices for reproducible patient setup, delineating whole breast or chest wall as well as nodal clinical target volumes, employing tangential fields with wedges or compensators for uniform dose distribution, and using additional fields like supraclavicular or internal mammary nodes when indicated. The goal is to adequately cover targets while minimizing doses to lungs, heart, and contralateral breast.
This document discusses hemi body irradiation (HBI) technique used to treat metastatic cancer. HBI involves irradiating only the upper or lower half of the body using parallel opposed radiation fields. It has advantages over total body irradiation like smaller field size and less side effects. HBI is used to palliate widely metastatic disease and as adjuvant therapy for certain cancers. Potential complications include nausea, diarrhea, pneumonitis and hematological effects. The document also provides an overview of cancer registries in India, which systematically collect cancer data to help understand cancer patterns and guide control programs. Population-based and hospital-based registries use active and passive methods to collect data on cancer incidence, stages and survival.
Principles of radiotherapy in gastric carcinomaAnil Gupta
This document discusses principles of radiotherapy for gastric carcinoma. It summarizes that post-operative radiotherapy can reduce local recurrence rates after surgery for gastric cancer, although no survival benefit has been proven. Newer radiation techniques like IMRT and VMAT may further reduce doses to organs-at-risk compared to 3D conformal radiotherapy. Pre-operative radiotherapy can also improve resectability in some inoperable cases.
The document discusses key concepts and parameters for prescribing, recording, and reporting photon beam therapy as defined by ICRU Report 50. It outlines volumes such as the gross tumor volume (GTV), clinical target volume (CTV), planning target volume (PTV), treated volume, and irradiated volume. It also discusses doses like the prescribed dose, maximum dose, and minimum dose. Parameters like the internal margin, set-up margin, and ICRU reference point and dose are introduced to help standardize reporting across centers for effective information exchange.
Conventional Brachytherapy in carcinoma cervixIsha Jaiswal
Brachytherapy plays a vital role in treating cervical cancer. It allows a high dose of radiation to be delivered to the tumor while sparing surrounding normal tissues. Historically, different brachytherapy systems such as Stockholm, Paris, and Manchester systems were used to prescribe dose based on empirical rules and measurements at reference points. More recently, the ICRU recommends a standardized approach for prescribing, recording, and reporting brachytherapy treatments based on dose distributions and volumes rather than single points to allow better comparison between treatments.
1) The document discusses various radiation techniques for treating cancer of the esophagus including 2D, 3D conformal radiation therapy, IMRT, and IGRT.
2) It covers topics like target volume delineation, field design considerations for different esophageal subsites, and evolution from 2D to 3D treatment planning.
3) While there is no consensus, most contemporary trials use margins of 3-5cm cranially and caudally on the gross tumor with approximately a 2cm radial margin.
This document discusses the use of stereotactic body radiation therapy (SBRT) for liver tumors. It provides details on common liver tumors including hepatocellular carcinoma and metastases. It describes SBRT as a treatment option for inoperable early stage tumors, as a bridge to transplant, and for intermediate or locally advanced stages. Key factors for patient selection and treatment planning such as tumor size, number and location, as well as liver function are summarized. The document also briefly discusses proton beam therapy and current clinical trials investigating SBRT for liver cancer.
This document discusses various radiotherapy techniques used for breast cancer treatment planning and delivery. It covers topics like positioning, immobilization, target volume delineation, treatment planning, dose prescription, and techniques to minimize doses to organs at risk. Some key points include the use of breast boards and immobilization devices for reproducible patient setup, delineating whole breast or chest wall as well as nodal clinical target volumes, employing tangential fields with wedges or compensators for uniform dose distribution, and using additional fields like supraclavicular or internal mammary nodes when indicated. The goal is to adequately cover targets while minimizing doses to lungs, heart, and contralateral breast.
This document discusses hemi body irradiation (HBI) technique used to treat metastatic cancer. HBI involves irradiating only the upper or lower half of the body using parallel opposed radiation fields. It has advantages over total body irradiation like smaller field size and less side effects. HBI is used to palliate widely metastatic disease and as adjuvant therapy for certain cancers. Potential complications include nausea, diarrhea, pneumonitis and hematological effects. The document also provides an overview of cancer registries in India, which systematically collect cancer data to help understand cancer patterns and guide control programs. Population-based and hospital-based registries use active and passive methods to collect data on cancer incidence, stages and survival.
Principles of radiotherapy in gastric carcinomaAnil Gupta
This document discusses principles of radiotherapy for gastric carcinoma. It summarizes that post-operative radiotherapy can reduce local recurrence rates after surgery for gastric cancer, although no survival benefit has been proven. Newer radiation techniques like IMRT and VMAT may further reduce doses to organs-at-risk compared to 3D conformal radiotherapy. Pre-operative radiotherapy can also improve resectability in some inoperable cases.
The document discusses key concepts and parameters for prescribing, recording, and reporting photon beam therapy as defined by ICRU Report 50. It outlines volumes such as the gross tumor volume (GTV), clinical target volume (CTV), planning target volume (PTV), treated volume, and irradiated volume. It also discusses doses like the prescribed dose, maximum dose, and minimum dose. Parameters like the internal margin, set-up margin, and ICRU reference point and dose are introduced to help standardize reporting across centers for effective information exchange.
Conventional Brachytherapy in carcinoma cervixIsha Jaiswal
Brachytherapy plays a vital role in treating cervical cancer. It allows a high dose of radiation to be delivered to the tumor while sparing surrounding normal tissues. Historically, different brachytherapy systems such as Stockholm, Paris, and Manchester systems were used to prescribe dose based on empirical rules and measurements at reference points. More recently, the ICRU recommends a standardized approach for prescribing, recording, and reporting brachytherapy treatments based on dose distributions and volumes rather than single points to allow better comparison between treatments.
1) The document discusses various radiation techniques for treating cancer of the esophagus including 2D, 3D conformal radiation therapy, IMRT, and IGRT.
2) It covers topics like target volume delineation, field design considerations for different esophageal subsites, and evolution from 2D to 3D treatment planning.
3) While there is no consensus, most contemporary trials use margins of 3-5cm cranially and caudally on the gross tumor with approximately a 2cm radial margin.
This document discusses the use of stereotactic body radiation therapy (SBRT) for liver tumors. It provides details on common liver tumors including hepatocellular carcinoma and metastases. It describes SBRT as a treatment option for inoperable early stage tumors, as a bridge to transplant, and for intermediate or locally advanced stages. Key factors for patient selection and treatment planning such as tumor size, number and location, as well as liver function are summarized. The document also briefly discusses proton beam therapy and current clinical trials investigating SBRT for liver cancer.
This document discusses the history and techniques of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). It begins by outlining the early development of SRS by Lars Leksell in the 1950s. It then defines key terms like SRS, SBRT, and fractionated stereotactic radiosurgery. The document goes on to discuss the rationale and advantages of SRS/SBRT, including its ability to deliver high radiation doses with steep dose gradients using multiple beams and image guidance. It also covers topics like tumor oxygenation, cell kill mechanisms, and recent technological advances in the field like VMAT, flattening filter free beams, and 4D
TBI is the radiotherapy technique to irradiate whole body before doing stem cell transplant. The main purpose of doing TBIB is to condition the immune system of body so that there will be maximum chance of transplant acceptance.
The document provides guidelines for contouring the clinical target volume (CTV) and organs at risk for carcinoma of the cervix treated with 3D conformal radiation therapy or intensity-modulated radiation therapy. The CTV includes the involved lymph nodes (GTV N) and relevant draining nodal groups. The CTV for the primary tumor (CTV-P) includes the gross tumor, uterus, cervix, parametrium, vagina, and ovaries. Detailed guidelines are provided for contouring the lymph node regions, uterus, vagina, and parametrium. A planning target volume (PTV) is created by adding a 10 mm margin to the total CTV. Additional margins are used to create an
The document provides guidance on contouring the hippocampus on MRI images for radiation treatment planning. It describes in detail how to contour each section of the hippocampus - the head, body, and tail - on axial MRI slices from inferior to superior. Landmarks used to define the boundaries include the temporal horn of the lateral ventricle, uncal recess, quadrigeminal cistern, and atrium of the lateral ventricle. A 5mm expansion of the hippocampus contour is used to create the hippocampal avoidance zone.
LDR and HDR Brachytherapy: A Primer for non radiation oncologistsSantam Chakraborty
A small presentation I made for a 30 minutes class comparing and contrasting LDR and HDR brachytherapy. Good for a person with non radiation oncology background to grasp the basics.
This document discusses target volume definitions in radiotherapy planning according to ICRU reports. It defines key volumes including the gross tumor volume (GTV), clinical target volume (CTV), internal target volume (ITV), planning target volume (PTV), treated volume, and irradiated volume. The CTV accounts for subclinical spread around the GTV, while margins are added to the CTV to create the ITV and PTV to account for organ motion and set-up uncertainties respectively. Together these volumes aim to ensure the prescribed dose is delivered to the tumor while minimizing dose to surrounding healthy tissues.
This presentation is intended to refer while doing planning of SBRT Prostate for all practical aspects from Simulation - contouring - planning - treatment. I am sure it will be very useful presentation for any radiation oncologist who are willing to start workflow of SBRT Prostate in the department of radiation oncology
Craniospinal irradiation involves treating the entire brain and spinal cord to prevent spread of certain cancers. It was pioneered in the 1950s for medulloblastoma and other tumors. The target area includes the brain, spinal cord down to S2 or S3. Planning challenges include immobilizing the large target area and minimizing dose inhomogeneity at field junctions. Techniques like prone positioning, double junction fields, and IMRT aim to deliver a uniform dose while sparing organs at risk.
Contouring in breast cancer current practice and future directions Anil Gupta
Contouring guidelines for breast cancer radiation therapy aim to define target volumes to adequately treat while minimizing toxicity. The RTOG and ESTRO guidelines provide consensus on contouring clinical target volumes (CTVs) for the breast/chest wall, lymph nodes, and organs at risk. However, some recurrences occur outside these guidelines. A study mapping 243 nodal recurrences found most were within RTOG or ESTRO CTVs, but out-of-field recurrences were often in the lateral and posterior supraclavicular region, particularly for young, triple-negative patients. While contouring guidelines provide standardization, individualized risk assessment may be needed to optimize local control versus toxicity.
This document summarizes guidelines for radiotherapy planning for lung cancer. It discusses:
- Defining the gross tumor volume (GTV) based on imaging like PET which can help reduce margins.
- Adding margins to the GTV to create the clinical target volume (CTV) accounting for microscopic spread. There is debate around elective nodal irradiation.
- Further expanding the CTV to create the planning target volume (PTV) accounting for set-up uncertainty and tumor motion. Techniques like gating can help reduce this.
- Contouring the lungs as organs at risk and calculating dosimetric parameters like V20 and V5 to quantify lung dose and risk of toxicity. Dose needs to
Icru reports in external beam radiotherapyDeepika Malik
The document summarizes key ICRU reports related to external beam radiotherapy, including ICRU Reports 29, 50, and 62. Report 29 established definitions like target volume, treatment volume, and organs at risk. Report 50 refined definitions and introduced clinical target volume, planning target volume, and treated volume. Report 62 further refined margins and introduced internal margin and setup margin. It also defined planning organ at risk volume and conformity index. The reports provide recommendations for dose reporting including minimum, maximum, and reference doses.
This document discusses craniospinal irradiation (CSI) techniques. It defines CSI as radiation delivered to the entire cranial-spinal axis. The document outlines the indications for CSI including various types of brain tumors. It then discusses the challenges of CSI due to the large irregular target volume and proximity to critical structures. The document focuses on the 3D conformal technique in supine position used at the author's department. It describes patient positioning, immobilization, simulation, target and organ at risk delineation, and treatment planning. Complications of CSI and the role of chemotherapy are also reviewed. Alternative CSI techniques like IMRT and proton therapy are mentioned but have limitations. Dosimetric studies find modern
This document discusses the basics of radiotherapy treatment plan evaluation. It covers topics such as defining the gross tumor volume (GTV), clinical target volume (CTV), planning target volume (PTV) and organs at risk (OAR). It describes dose volume histograms (DVHs) and how to analyze metrics like the median dose, minimum and maximum doses received by the target and OARs. Other areas covered include isodose lines, equivalent radiation, conformity and homogeneity indices, and ensuring appropriate dose coverage of the target while sparing OARs. The document emphasizes balancing target coverage with OAR protection in treatment plan evaluation.
Isodose curves depict absorbed dose distributions and variations in volume and planes. They join points of equal dose. Isodose charts show the variation in dose as a function of depth and transverse distance from the central beam axis. Factors like beam energy, field size, and distance affect isodose curve shape through penumbra and dose deposition. Multiple beams are often needed to adequately treat tumors while sparing surrounding tissues. Beam arrangements, weights, and modifiers must be optimized for each plan.
Prophylactic cranial irradiation (PCI) is used to prevent brain metastases in cancers with a high risk of spreading to the brain. It is indicated for small cell lung cancer and certain leukemias. PCI significantly reduces the rate of brain metastases in small cell lung cancer, especially when administered early at higher doses. For extensive stage small cell lung cancer, MRI surveillance may be an alternative to PCI. While PCI reduces brain metastases in leukemia, the risk of brain involvement is low for some types such as AML. The standard dose for PCI is 1200-1800 cGy in fractions, with timing and volumes depending on the cancer type. Potential toxicities include neurocognitive effects, endocrine disorders, and secondary cancers.
The ICRU was conceived in 1925 to propose a unit for measuring radiation in medicine. It is now responsible for defining units of measure for radiation quantities and developing recommendations on their safe application. The ICRU works with committees to publish reports on topics like radiation therapy, dosimetry, and protection. Its goals are to evaluate data on ionizing radiation and maintain contacts to benefit radiation science.
Brachytherapy involves placing radioactive sources close to or inside the treatment area. The document discusses the history and discovery of radium and its use in early brachytherapy treatments. It then describes various brachytherapy techniques including interstitial, intracavitary, surface mould therapy and different remote afterloading systems. Key brachytherapy sources such as Cs-137, Ir-192, Co-60 and their properties are also outlined. Measurement units for source strength including air kerma rate and exposure rate constants are defined.
This document discusses reirradiation in recurrent head and neck cancer. It notes that radiation therapy plays a central role in head and neck cancer treatment but recurrence still occurs in 20-35% of patients. Reirradiation presents challenges due to prior radiation exposure and damage to normal tissues. The document discusses treatment options, appropriate patient selection, techniques like IMRT to minimize dose to organs at risk, optimal timing and dosing of reirradiation, and management of toxicities.
This document provides guidance on contouring for nasopharyngeal carcinoma (NPC) radiation treatment planning. It discusses the anatomy and patterns of spread of NPC, as well as staging. It describes how to delineate the primary gross tumor volume (GTVp), clinical target volumes (CTVs) including high-risk (CTVp1) and intermediate-risk (CTVp2) volumes. It also covers nodal CTV delineation (CTVn1, CTVn2, CTVn3) and discusses lymph node levels and risk of spread. Margins around critical organs and intracranial extension guidelines are also summarized. The document aims to provide a comprehensive overview of target volume delineation for NPC
This document provides information about total body irradiation (TBI). It discusses that TBI uses megavoltage photon beams to destroy the recipient's bone marrow and tumor cells prior to bone marrow transplantation. It is used to treat various diseases like leukemia, lymphoma, and multiple myeloma. TBI can be delivered at high or low doses, to half the body, or total nodes. Techniques include parallel opposed beams from linear accelerators or cobalt-60 machines. Dosimetry and in vivo dosimetry are important due to the large fields and difficulty achieving uniform dose. Complications can include sterility, secondary cancers, and growth issues.
The document describes various anatomical triangles of the neck region. It discusses 11 triangles in detail, providing their boundaries, contents, and clinical significance. The triangles described include the anterior triangle, submental triangle, submandibular triangle, carotid triangle, muscular triangle, posterior triangle, occipital triangle, and supraclavicular triangle. Structures like nerves, vessels, muscles and lymph nodes contained within each triangle are outlined. Potential surgical and pathological implications are also mentioned.
The document discusses the anatomy of the anterior triangle of the neck. It begins by outlining the boundaries and contents of the anterior triangle. It then describes how the triangle is divided into four smaller triangles - the submental, submandibular, carotid, and muscular triangles - by the digastric and omohyoid muscles. Each smaller triangle's boundaries, floor, contents, and structures are defined in detail. Key structures discussed include the thyroid gland, carotid sheath, carotid sinus, and carotid body. Blood supply and lymphatic drainage of the thyroid gland are also summarized.
This document discusses the history and techniques of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). It begins by outlining the early development of SRS by Lars Leksell in the 1950s. It then defines key terms like SRS, SBRT, and fractionated stereotactic radiosurgery. The document goes on to discuss the rationale and advantages of SRS/SBRT, including its ability to deliver high radiation doses with steep dose gradients using multiple beams and image guidance. It also covers topics like tumor oxygenation, cell kill mechanisms, and recent technological advances in the field like VMAT, flattening filter free beams, and 4D
TBI is the radiotherapy technique to irradiate whole body before doing stem cell transplant. The main purpose of doing TBIB is to condition the immune system of body so that there will be maximum chance of transplant acceptance.
The document provides guidelines for contouring the clinical target volume (CTV) and organs at risk for carcinoma of the cervix treated with 3D conformal radiation therapy or intensity-modulated radiation therapy. The CTV includes the involved lymph nodes (GTV N) and relevant draining nodal groups. The CTV for the primary tumor (CTV-P) includes the gross tumor, uterus, cervix, parametrium, vagina, and ovaries. Detailed guidelines are provided for contouring the lymph node regions, uterus, vagina, and parametrium. A planning target volume (PTV) is created by adding a 10 mm margin to the total CTV. Additional margins are used to create an
The document provides guidance on contouring the hippocampus on MRI images for radiation treatment planning. It describes in detail how to contour each section of the hippocampus - the head, body, and tail - on axial MRI slices from inferior to superior. Landmarks used to define the boundaries include the temporal horn of the lateral ventricle, uncal recess, quadrigeminal cistern, and atrium of the lateral ventricle. A 5mm expansion of the hippocampus contour is used to create the hippocampal avoidance zone.
LDR and HDR Brachytherapy: A Primer for non radiation oncologistsSantam Chakraborty
A small presentation I made for a 30 minutes class comparing and contrasting LDR and HDR brachytherapy. Good for a person with non radiation oncology background to grasp the basics.
This document discusses target volume definitions in radiotherapy planning according to ICRU reports. It defines key volumes including the gross tumor volume (GTV), clinical target volume (CTV), internal target volume (ITV), planning target volume (PTV), treated volume, and irradiated volume. The CTV accounts for subclinical spread around the GTV, while margins are added to the CTV to create the ITV and PTV to account for organ motion and set-up uncertainties respectively. Together these volumes aim to ensure the prescribed dose is delivered to the tumor while minimizing dose to surrounding healthy tissues.
This presentation is intended to refer while doing planning of SBRT Prostate for all practical aspects from Simulation - contouring - planning - treatment. I am sure it will be very useful presentation for any radiation oncologist who are willing to start workflow of SBRT Prostate in the department of radiation oncology
Craniospinal irradiation involves treating the entire brain and spinal cord to prevent spread of certain cancers. It was pioneered in the 1950s for medulloblastoma and other tumors. The target area includes the brain, spinal cord down to S2 or S3. Planning challenges include immobilizing the large target area and minimizing dose inhomogeneity at field junctions. Techniques like prone positioning, double junction fields, and IMRT aim to deliver a uniform dose while sparing organs at risk.
Contouring in breast cancer current practice and future directions Anil Gupta
Contouring guidelines for breast cancer radiation therapy aim to define target volumes to adequately treat while minimizing toxicity. The RTOG and ESTRO guidelines provide consensus on contouring clinical target volumes (CTVs) for the breast/chest wall, lymph nodes, and organs at risk. However, some recurrences occur outside these guidelines. A study mapping 243 nodal recurrences found most were within RTOG or ESTRO CTVs, but out-of-field recurrences were often in the lateral and posterior supraclavicular region, particularly for young, triple-negative patients. While contouring guidelines provide standardization, individualized risk assessment may be needed to optimize local control versus toxicity.
This document summarizes guidelines for radiotherapy planning for lung cancer. It discusses:
- Defining the gross tumor volume (GTV) based on imaging like PET which can help reduce margins.
- Adding margins to the GTV to create the clinical target volume (CTV) accounting for microscopic spread. There is debate around elective nodal irradiation.
- Further expanding the CTV to create the planning target volume (PTV) accounting for set-up uncertainty and tumor motion. Techniques like gating can help reduce this.
- Contouring the lungs as organs at risk and calculating dosimetric parameters like V20 and V5 to quantify lung dose and risk of toxicity. Dose needs to
Icru reports in external beam radiotherapyDeepika Malik
The document summarizes key ICRU reports related to external beam radiotherapy, including ICRU Reports 29, 50, and 62. Report 29 established definitions like target volume, treatment volume, and organs at risk. Report 50 refined definitions and introduced clinical target volume, planning target volume, and treated volume. Report 62 further refined margins and introduced internal margin and setup margin. It also defined planning organ at risk volume and conformity index. The reports provide recommendations for dose reporting including minimum, maximum, and reference doses.
This document discusses craniospinal irradiation (CSI) techniques. It defines CSI as radiation delivered to the entire cranial-spinal axis. The document outlines the indications for CSI including various types of brain tumors. It then discusses the challenges of CSI due to the large irregular target volume and proximity to critical structures. The document focuses on the 3D conformal technique in supine position used at the author's department. It describes patient positioning, immobilization, simulation, target and organ at risk delineation, and treatment planning. Complications of CSI and the role of chemotherapy are also reviewed. Alternative CSI techniques like IMRT and proton therapy are mentioned but have limitations. Dosimetric studies find modern
This document discusses the basics of radiotherapy treatment plan evaluation. It covers topics such as defining the gross tumor volume (GTV), clinical target volume (CTV), planning target volume (PTV) and organs at risk (OAR). It describes dose volume histograms (DVHs) and how to analyze metrics like the median dose, minimum and maximum doses received by the target and OARs. Other areas covered include isodose lines, equivalent radiation, conformity and homogeneity indices, and ensuring appropriate dose coverage of the target while sparing OARs. The document emphasizes balancing target coverage with OAR protection in treatment plan evaluation.
Isodose curves depict absorbed dose distributions and variations in volume and planes. They join points of equal dose. Isodose charts show the variation in dose as a function of depth and transverse distance from the central beam axis. Factors like beam energy, field size, and distance affect isodose curve shape through penumbra and dose deposition. Multiple beams are often needed to adequately treat tumors while sparing surrounding tissues. Beam arrangements, weights, and modifiers must be optimized for each plan.
Prophylactic cranial irradiation (PCI) is used to prevent brain metastases in cancers with a high risk of spreading to the brain. It is indicated for small cell lung cancer and certain leukemias. PCI significantly reduces the rate of brain metastases in small cell lung cancer, especially when administered early at higher doses. For extensive stage small cell lung cancer, MRI surveillance may be an alternative to PCI. While PCI reduces brain metastases in leukemia, the risk of brain involvement is low for some types such as AML. The standard dose for PCI is 1200-1800 cGy in fractions, with timing and volumes depending on the cancer type. Potential toxicities include neurocognitive effects, endocrine disorders, and secondary cancers.
The ICRU was conceived in 1925 to propose a unit for measuring radiation in medicine. It is now responsible for defining units of measure for radiation quantities and developing recommendations on their safe application. The ICRU works with committees to publish reports on topics like radiation therapy, dosimetry, and protection. Its goals are to evaluate data on ionizing radiation and maintain contacts to benefit radiation science.
Brachytherapy involves placing radioactive sources close to or inside the treatment area. The document discusses the history and discovery of radium and its use in early brachytherapy treatments. It then describes various brachytherapy techniques including interstitial, intracavitary, surface mould therapy and different remote afterloading systems. Key brachytherapy sources such as Cs-137, Ir-192, Co-60 and their properties are also outlined. Measurement units for source strength including air kerma rate and exposure rate constants are defined.
This document discusses reirradiation in recurrent head and neck cancer. It notes that radiation therapy plays a central role in head and neck cancer treatment but recurrence still occurs in 20-35% of patients. Reirradiation presents challenges due to prior radiation exposure and damage to normal tissues. The document discusses treatment options, appropriate patient selection, techniques like IMRT to minimize dose to organs at risk, optimal timing and dosing of reirradiation, and management of toxicities.
This document provides guidance on contouring for nasopharyngeal carcinoma (NPC) radiation treatment planning. It discusses the anatomy and patterns of spread of NPC, as well as staging. It describes how to delineate the primary gross tumor volume (GTVp), clinical target volumes (CTVs) including high-risk (CTVp1) and intermediate-risk (CTVp2) volumes. It also covers nodal CTV delineation (CTVn1, CTVn2, CTVn3) and discusses lymph node levels and risk of spread. Margins around critical organs and intracranial extension guidelines are also summarized. The document aims to provide a comprehensive overview of target volume delineation for NPC
This document provides information about total body irradiation (TBI). It discusses that TBI uses megavoltage photon beams to destroy the recipient's bone marrow and tumor cells prior to bone marrow transplantation. It is used to treat various diseases like leukemia, lymphoma, and multiple myeloma. TBI can be delivered at high or low doses, to half the body, or total nodes. Techniques include parallel opposed beams from linear accelerators or cobalt-60 machines. Dosimetry and in vivo dosimetry are important due to the large fields and difficulty achieving uniform dose. Complications can include sterility, secondary cancers, and growth issues.
The document describes various anatomical triangles of the neck region. It discusses 11 triangles in detail, providing their boundaries, contents, and clinical significance. The triangles described include the anterior triangle, submental triangle, submandibular triangle, carotid triangle, muscular triangle, posterior triangle, occipital triangle, and supraclavicular triangle. Structures like nerves, vessels, muscles and lymph nodes contained within each triangle are outlined. Potential surgical and pathological implications are also mentioned.
The document discusses the anatomy of the anterior triangle of the neck. It begins by outlining the boundaries and contents of the anterior triangle. It then describes how the triangle is divided into four smaller triangles - the submental, submandibular, carotid, and muscular triangles - by the digastric and omohyoid muscles. Each smaller triangle's boundaries, floor, contents, and structures are defined in detail. Key structures discussed include the thyroid gland, carotid sheath, carotid sinus, and carotid body. Blood supply and lymphatic drainage of the thyroid gland are also summarized.
This document describes the anatomy of the neck relevant to neck dissection surgery. It outlines the boundaries of the neck, key muscles and structures like the platysma, sternocleidomastoid, trapezius and vessels. It discusses the lymph node levels and types of neck dissection surgeries like radical and selective dissections. The document provides details of the surgical approach including skin incisions and dissection of structures to completely remove lymph nodes while preserving nearby nerves and vessels.
This document provides an overview of the surgical anatomy of the neck. It describes the boundaries and landmarks of the neck, including the upper and lower borders. It details the structures found in the root of the neck, as well as the mandible, hyoid bone, thyroid cartilage, cricoid cartilage, trachea, and thyroid gland. It discusses the superficial muscles of the neck, including the platysma and sternocleidomastoid muscles. It provides an in-depth description of the fascia of the neck, including the superficial and deep cervical fascia. It outlines the contents and boundaries of the anterior, posterior, and lateral triangles of the neck. Finally, it briefly discusses the cervical lymph nodes.
The posterior triangle of the neck contains several important structures:
1) It is bounded by the sternocleidomastoid muscle, clavicle, and upper border of the scapula.
2) It contains the accessory nerve, branches of the cervical plexus, and components of the brachial plexus like the dorsal scapular nerve.
3) Important arteries like the subclavian artery and veins like the external jugular vein pass through it.
This document provides an overview of neck dissection procedures. It discusses the history and evolution of neck dissection, from Kocher's initial proposal in 1880 to remove nodal metastases to more modern classifications. The surgical anatomy of neck structures is described in detail. Levels of cervical lymph nodes are defined based on boundaries of bones, muscles, blood vessels and nerves. Staging of head and neck cancers using the TNM system is explained. Factors affecting nodal metastasis and techniques for assessing cervical lymph nodes are also summarized.
The document discusses various neck swellings including:
1) Thyroglossal cyst - Arises from remnants of the thyroglossal duct and requires complete excision (Sistrunk's operation) to prevent recurrence.
2) Branchial cyst - Develops from vestigial remnants of the second branchial cleft and is excised when non-infected.
3) Cystic hygroma - Filled with clear lymph due to sequestration of lymph sac and often presents in neonates, requiring complete early excision.
The document discusses the anatomy and triangles of the neck, describing boundaries, contents, and clinical significance. It also covers common neck masses including cysts, sinuses, fistulas, ulcers, tumors, and infections. Lymphatic drainage is described for deep cervical nodes along vertical and circular chains.
The neck is divided into anterior and posterior triangles by the sternocleidomastoid muscle. The anterior triangle contains major blood vessels and nerves and is further divided into subdivisions. The posterior triangle contains the spinal accessory nerve, brachial plexus, and lymph nodes. Both triangles have muscles, vessels and nerves that can be clinically significant. The document provides details on the boundaries, contents, and clinical relevance of the triangles of the neck.
Surgical anatomy of neck and types of neck dissectionSanika Kulkarni
The document discusses the anatomy of the neck including fascial layers, muscles, triangles, contents, nerves, vessels and lymph nodes. It provides a detailed overview of the surgical anatomy and classifications of neck dissections. The classifications include the Academy's classification of radical, modified radical and selective neck dissections. It also discusses Medina and Spiro's classifications of neck dissections.
Boundaries of the carotid triangle are:
posterior belly of digastric muscle (pbd)
superior belly of the omohyoid muscle (so)
anterior border of sternomastoid muscle (st)
Lymph nodes in the head and neck can be examined and classified into different levels. There are about 300 lymph nodes in the head and neck region organized into two circles - the outer and inner circles. The outer circle includes submental, submandibular, preauricular and occipital nodes. The inner circle includes prelaryngeal, pretracheal, paratracheal and retropharyngeal nodes. Lymph nodes are further classified into 6 levels from I to VI based on their location for cancer staging and treatment planning. Lymph nodes examine antigen filtration and immune response initiation making examination important for clinical assessment.
The document discusses contouring and delineation of target volumes for breast cancer radiation therapy. It provides detailed descriptions of the cranial, caudal, medial, lateral, anterior and posterior borders for clinical target volumes (CTVs) in different lymph node regions including axillary levels I-III, supraclavicular, internal mammary, and breast/chest wall. Precise delineation of targets is important for effective radiation treatment while minimizing dose to surrounding healthy tissues.
The clinical Anatomy of the Thorax. eng.pdfSonyChowdary4
This document provides an overview of the clinical anatomy of the thorax. It discusses the structures and boundaries of the thorax, including landmarks like the clavicles, sternum, ribs, and costal margins. Methods for examining the thorax like percussion, auscultation, imaging tests, and endoscopy are outlined. Key contents of the thorax are described, such as the lungs, heart, blood vessels, nerves and fascial layers. Common thoracic anomalies and diseases involving the lungs and chest wall are also reviewed.
The carotid sheath is located in the neck from the base of the skull to the root of the neck. It contains the internal carotid artery, internal jugular vein, vagus nerve, and branches of the sympathetic trunk. The common carotid artery bifurcates into the internal and external carotid arteries around the level of the thyroid cartilage between vertebrae C3 and C4. The structures within the carotid sheath have important relationships that provide pathways for infection spread.
This document discusses neck dissections and related anatomy. It covers the layers of fascia in the neck, important muscles and structures, lymph node levels, types of neck incisions and dissections, and complications. The key types of neck dissections are radical, modified radical, and selective neck dissections. Common neck incisions discussed include transverse, Criles, apron, and double Y incisions.
The document discusses the anatomy of the triangles of the neck. It describes the boundaries, contents, and structures related to the anterior and posterior triangles. The anterior triangle is further divided into four triangles by the digastric and omohyoid muscles. The submandibular triangle contains the submandibular gland, submandibular lymph nodes, hypoglossal nerve, and the external and internal carotid arteries. The mylohyoid muscle forms the floor of the submandibular triangle.
The document describes the triangles of the neck, including boundaries, contents, and clinical significance. It discusses the carotid triangle, containing the carotid arteries and jugular vein within the carotid sheath. The muscular triangle contains the infrahyoid muscles between the hyoid bone and sternum. The digastric triangle posterior to the mandible contains the submandibular gland and facial vessels. The posterior triangle posterior to the sternocleidomastoid contains the spinal accessory nerve and external jugular vein, with the retropharyngeal space inferiorly. Care must be taken during neck surgery or procedures to avoid injuring structures like nerves and vessels within these anatomical spaces.
This document discusses skin cancer, specifically melanoma. It notes that melanoma accounts for 1-5% of skin cancers but causes the majority of skin cancer deaths. Risk factors include family history, sun exposure, skin sensitivity, and immunosuppression. The main types of melanoma are superficial spreading, nodular, lentigo maligna, and acral lentiginous. Diagnosis involves examining lesions for characteristics like asymmetry, irregular border, multiple colors, diameter over 6mm, and changes over time. Treatment depends on cancer stage and may include surgery, radiation, immunotherapy, targeted therapy, chemotherapy, or a combination.
Sarcoma represents 1% of all malignant tumors and includes soft tissue sarcomas (STS), bone sarcomas, and visceral sarcomas. STS are more common than bone sarcomas by a ratio of 4:1. Risk factors for sarcoma include genetic syndromes, radiation exposure, and certain chemical exposures. Diagnosis involves imaging such as MRI or CT along with pathological confirmation. Treatment depends on the location and stage of disease, and may involve surgery, radiation therapy, chemotherapy, or targeted therapy. The goal is curative treatment for localized disease and palliation for metastatic disease.
Thyroid cancer is the most common cancer of the endocrine system. The three main types are papillary, follicular, and medullary thyroid carcinoma. Risk factors include radiation exposure, family history, and genetic conditions. Symptoms may include a neck mass, lymph node swelling, difficulty swallowing or breathing, and diarrhea. Diagnosis involves thyroid imaging tests, biopsy, and genetic testing. Treatment depends on cancer type and stage but commonly includes surgery, radioactive iodine therapy, and medication for differentiated cancers, and surgery plus other therapies for medullary and anaplastic thyroid cancers.
Head and neck cancer is the 6th most common cancer worldwide. The incidence increases with age, with most cases being diagnosed after age 60. It is also more common in men. Risk factors include cigarette smoking, HPV or EBV infection, alcohol intake, and prior history of head and neck cancer or radiation exposure. The most common type is squamous cell carcinoma. Symptoms depend on the location but may include masses, ulcers, pain, swallowing difficulties, voice changes, and sinus problems. Diagnosis involves endoscopy, imaging tests, and biopsy. Staging depends on tumor size and spread. Treatment options include surgery, radiation therapy, chemotherapy, and biological therapies depending on cancer type and stage.
Testicular tumors are the most common cancer in men aged 20-40. They make up about 1% of all cancers in men. Risk factors include family history, undescended testes, infertility, and genetic conditions. The majority are germ cell tumors which are divided into seminomas and non-seminomas. Common symptoms are a painless mass in the scrotum or painful enlargement of the testis. Diagnosis involves blood tests, ultrasound, and CT scans. Staging determines the appropriate treatment which may include surgery, radiation therapy, chemotherapy, or active surveillance depending on the stage and type of tumor.
Prostate cancer is the second most common cancer in men worldwide and the second most common cause of cancer death in men. It makes up around 10-15% of all male cancers. Hereditary factors like mutations in the BRCA1 and BRCA2 genes and a family history of prostate cancer can increase the risk. Screening tests for prostate cancer include a digital rectal exam and PSA blood test. Treatment depends on the stage and grade of cancer, and may include surgery, radiation therapy, hormone therapy, chemotherapy, and palliative care.
Bladder cancer is the 4th most common cancer in men worldwide, with a peak incidence around age 65. Risk factors include smoking, occupational exposure, and certain infections. Symptoms depend on whether the cancer is non-metastatic or metastatic, and may include blood in the urine, bladder irritability, and pelvic or flank pain. Diagnosis involves cystoscopy, imaging tests, and urine cytology. Treatment depends on the stage, and includes surgery, chemotherapy, and immunotherapy.
Renal cancer, also known as renal cell carcinoma (RCC), is the 12th most common cancer worldwide and the 4th most common cancer in adult males. Risk factors include hereditary conditions, smoking, obesity, and hypertension. Symptoms can include hematuria, flank mass, flank pain, and paraneoplastic syndromes in metastatic disease. Diagnosis involves imaging like CT scans and labs. Treatment depends on stage - surgery is recommended for localized disease while targeted drugs, immunotherapy, and surgery are options for metastatic renal cancer.
DNA repair systems help maintain the integrity of genetic material by correcting damage from mutagens. There are several types of DNA repair mechanisms, including direct damage reversal, mismatch repair, base excision repair, nucleotide excision repair, and recombination repair. Key DNA repair proteins like p53 play an important role in recognizing DNA damage and initiating cell cycle arrest to allow time for repair or inducing apoptosis if damage is irreparable. Double strand breaks are the most difficult to repair and can lead to chromosomal rearrangements if unrepaired.
Apoptosis is a genetically programmed cell death process that eliminates unwanted cells through activation of caspases. There are two main pathways that activate caspases - the extrinsic death receptor pathway where ligands bind to cell surface receptors, and the intrinsic mitochondrial pathway where increased permeability of mitochondria releases proteins that activate caspase. The Bcl-2 family of proteins regulate apoptosis by integrating both pro-apoptotic and anti-apoptotic signals to determine if a cell should undergo programmed cell death.
Cancer genes can be divided into two main classes: oncogenes and tumor suppressor genes. Oncogenes promote cell growth and proliferation when activated by mutations, while tumor suppressor genes normally inhibit cell growth and their inactivation allows for unchecked cell division. Dysfunction of multiple cancer genes is typically required for malignant transformation, as an imbalance between oncogene and tumor suppressor gene activity leads to cancer development. Common oncogenes include ras, myc, and HER2, while tumor suppressor genes include RB, p53, and APC. Mutations in DNA repair genes can also contribute to cancer by allowing genetic errors to persist.
The document discusses the cell cycle and its control. It describes the cell cycle as consisting of interphase (which includes G1, S, and G2 phases) and mitosis (M phase). Interphase involves cell growth and DNA replication, while mitosis involves the division of the cell into two daughter cells. Transition between phases is regulated by cyclins and cyclin-dependent kinases (Cdks). Key checkpoints ensure replication and division occur accurately. The centromere and chromatids are also described along with their behavior in the different mitotic phases.
1) Cancer metastasis is a multi-step process involving invasion of surrounding tissue, transportation through the bloodstream, and formation of tumors in distant organs.
2) Key steps include degradation of the extracellular matrix, entry and survival in the circulation, arrest and extravasation at distant sites, and induction of angiogenesis to establish blood supply for growing tumors.
3) Factors such as matrix metalloproteinases, integrins, and angiogenic growth factors regulate these steps by promoting degradation of barriers, cell adhesion, and new blood vessel formation to enable metastatic tumors to grow.
Cancer cells exhibit six hallmarks that allow tumor growth and metastasis. They are: self-sufficiency in growth signals, insensitivity to anti-growth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. Cancer cells achieve these hallmarks through genetic and epigenetic alterations that disrupt normal cell signaling pathways.
1) Carcinogenesis is a multistep process involving initiation, promotion, and progression. Initiation involves genetic mutations from environmental factors like smoking. Promotion involves clonal expansion driven by growth factors in a reversible stage. Progression results in irreversible aneuploidy and cellular anaplasia.
2) The multihit hypothesis proposes cancer develops through accumulation of multiple genetic mutations in oncogenes and tumor suppressor genes, requiring 4-5 mutations for malignancy.
3) Cancers arise from a single cell of origin (monoclonal) that accumulates mutations over time, leading to intratumor heterogeneity as subclones evolve. Evidence for monoclonal origin includes single enzyme/immunoglob
This document discusses various diagnostic tools used in oncology, including tumor markers, immunohistochemistry, immunocytology, cytogenetics, molecular diagnosis, and gene expression analysis. It provides details on tumor markers including their definition, classification, factors that affect serum levels, and indications for use. It also discusses immunohistochemistry in detail, covering tumor antigens, immunoreactivity, clinical applications for diagnosis, predicting therapy response and prognosis, and specific carcinoma markers like cytokeratins, CEA, and hormone receptors.
There are 9 main classes of cancer: carcinomas, neuroectodermal tumors, sarcomas, hemolymphoid tumors, germ cell tumors, blastemal tumors, embryonal vestigal remnants tumors, uncertain histogenesis tumors, and undifferentiated tumors. Carcinomas are the most common type, arising from epithelial cells. Sarcomas arise from mesenchymal cells and grow more rapidly than carcinomas. Neuroectodermal tumors include tumors of neural, neuroendocrine, and primitive neuroectodermal origin. Hemolymphoid malignancies include lymphomas and leukemias. Other classes are defined by their origin from germ cells, embryonic rests, vestigial remnants
Neoplasia refers to abnormal tumor growth. There are two main types of tumors: benign tumors, which remain localized and do not recur after removal, and malignant tumors, which invade surrounding tissues and can metastasize to distant sites. Benign tumors are well-defined masses that grow slowly by expansion, while malignant tumors are poorly defined masses that grow rapidly by infiltration. Microscopically, benign tumor cells resemble normal cells and have few blood vessels and mitoses, whereas malignant tumor cells are poorly differentiated with irregular nuclei, frequent mitoses, and necrosis. Malignant tumors can recur after removal and are always a health risk.
This document discusses the etiology of cancer. It classifies etiological factors into extrinsic (chemical, physical, biological) and intrinsic (genetic, hormonal, immune) factors. Extrinsic factors predominate in causing adult cancers while intrinsic factors are more common in pediatric cancers. Major extrinsic factors include chemicals, radiation, infections, and tobacco. Chemicals can directly or indirectly damage DNA. Radiation can directly or indirectly ionize DNA. Certain viruses and bacteria are associated with specific cancer types. The interaction between multiple genetic and environmental factors usually leads to cancer development.
This document discusses various disorders of growth including hypertrophy, hyperplasia, metaplasia, dysplasia, carcinoma in situ, and precancerous lesions.
Hypertrophy is an increase in size of cells and organelles leading to organ enlargement. Hyperplasia is an increase in cell number, often with some hypertrophy. Metaplasia is a reversible change where one adult cell type replaces another of the same category. Dysplasia is a disorder of growth seen as abnormal cell maturation and arrangement. Carcinoma in situ represents severe dysplasia involving the entire epithelium but no invasion. Precancerous lesions are non-malignant conditions that may undergo malignant transformation.
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
The Children are very vulnerable to get affected with respiratory disease.
In our country, the respiratory Disease conditions are consider as major cause for mortality and Morbidity in Child.
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient.
One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells.
Safe methods have been devised to do this, using several viral and non-viral vectors.
In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria:
Protection of transgene or genetic cargo from degradative action of systemic and endonucleases,
Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus,
Low potential of triggering unwanted immune responses or genotoxicity,
Economical and feasible availability for patients .
Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells.
Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination.
There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo.
The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.
1. Delineation in Breast Cancer (Part II)
Mohammed Fathy Bayomy, MSc, MD
Lecturer
Clinical Oncology & Nuclear Medicine
Faculty of Medicine
Zagazig University
28. CT anatomy of target volume
• Upper end: supraclavicular region
• Lower end: 1-1.5 cm below breast
• Upper part of the volume: lymphatics of supraclavicular
and apex axilla lymph nodes
• Middle & lower part of the volume: lymphatic level I & II
of axillary nodes + internal mammary nodes + breast (post
conservative surgery &/or chest wall (post-MRM)
30. SCV fossa
• Lesser SCV fossa: depression between two
heads of sternocleidomastoid muscle.
• Greater SCV fossa: at base of posterior
triangle of neck = omoclavicular triangle
Subdivided into two compartments
31. • Medial: extend to lateral edge of trachea,
excluding thyroid gland and thyroid
cartilage.
• Anterior: deep surface of
sternocleidomastoid muscle & deep cervical
fascia.
• Posterolateral (cranial): anterior & medial
borders of anterior scalene muscle.
• Posteromedial (cranial): extend medially to
carotid artery & internal jugular vein.
• Posterior (caudal): subclavian artery.
52. ICV fossa
• Superior : pectoralis minor muscle
• Inferior : level of insertion of clavicle into
manubrium.
• Lateral : medial border of pectoralis minor muscle.
• Medial : lateral edge of clavicle.
• Anterior : deep surface of pectoralis major.
• Posterior : subclavian & axillary artery.
91. Caudal
Loss of apparent breast
Clinical referenceClinical reference
CranialCranial
CaudalCaudal
Anterior
AnteriorPosterior
Posterior
LateralMedial
LateralMedial
CoronalSagittal
Axial
X
154. Supraclavicular lymph node
• Superior: begin at inferior border of cricoid cartilage.
• Inferior: extend to cranial border of clavicular head.
• Anterior: sternocleidomastoid muscle (cranial), clavicle (caudal).
• Anterolateral: lateral edge of sternocleidomastoid (cranial), lateral
border of clavicle (caudal).
• Posterolateral: anterior scalene muscle.
• Posteromedial: medial to carotid artery & internal jugular vein.
155. Infraclavicular lymph node
• Superior: superior border of pectoralis minor muscle.
• Inferior: superior border of sternum.
• Anterior: pectoralis major muscle.
• Posterior: ribs & intercostal muscles.
• Lateral: medial border of pectoralis minor muscle.
• Medial: lateral edge of clavicle
159. Left Common Carotid Artery (CCA)
Left Internal Jugular Vein (IJV)
Middle & Posterior Scalene muscles
Thyroid gland
Trachea
Esophagus
Clavicle
Coracoid process of scapula
First Rib
First Thoracic
Vertebrae (D1)
Axial Anterior
Posterior
Lateral
161. Left Common Carotid Artery (CCA)
Trachea
Esophagus
Clavicle
First Rib
Second Rib
Third Rib
Sternothyroid &
Sternohyoid muscle
Apex of
lung
Second Thoracic
Vertebrae (D2)
Scapula
Head of Humerous
Pectoralis major
Serratus anterior
muscle
Spine of Scapula
Supraspinatus
muscle
Subscapularis
muscleIntercostal
muscle
Subclavius muscle
Left Subclavian vein
Left Subclavian
artery
Left Internal Jugular Vein (IJV)
Anterior
Posterior
Medial Lateral
163. Pectoralis major
SSN
Subscapularis
muscle
Scapula
Spine of Scapula
Supraspinatus
muscle
Serratus anterior
muscle
Clavicle
Left Axillary artery
Left Axillary vein
Left Subclavian
artery
Left Common Carotid
Artery (CCA)
Left Brachiocephalic
vein
Trachea
Esophagus
First Rib
Second Rib
Third Rib
Fourth Rib (head)
Third Thoracic
Vertebrae (D3)
Infraspinatus muscle
Axial Anterior
Posterior
Medial Lateral
165. Clavicle
Pectoralis major
Left Subclavian
artery
Left Common Carotid
Artery (CCA)
Esophagus
Trachea
Left Brachiocephalic
vein
First Rib
Fourth Rib
Third Rib
Second Rib
Serratus anterior
muscle
Infraspinatus muscle
Subscapularis
muscle
Scapula
Axial Anterior
Posterior
Medial Lateral
167. Breast (Post lumpectomy)
• Breast CTV: include all mammary glandular tissue.
• Lateral border: difficult to define especially with gland involution,
lateral thoracic vessel with lateral mammary braches may be used
as surrogate marker.
• Cranial border: difficult to define especially with gland involution,
inferior edge of clavicle may be used as surrogate marker.
• Medial border: difficult to define especially with gland involution,
lateral edge of sternum may be used as surrogate marker.
175. Tumor Bed (Boost)
• CTV boost: tumor bed (GTV) + 5mm in all direction without
exceeding CTV breast
• Tumor bed: include all surgically inserted clips, solid tissue and/or
seroma in-between.
• Data come from: preoperative mammography,
mammosonography, MR mammography, operative data.
• Surgical clips: surgeons insert 4-6 clips in post-lumpectomy cavity.
• Oncoplastic surgery: clips is inserted before transposition & be
aware of possible movement of clips.
178. Chest wall (postmastectomy)
• CTV chest wall: guided by position of contralateral breast.
• Borders & MRM scar: marked with radioopaque wires.
• MRM scar: cover only part with breast region.
• Caudal border: 3 cm caudal to MRM scar (bilateral MRM)
• Ventral border: 5 mm below skin except 3cm above to 3cm below
scar >>> 3-6 mm bolus is applied
• Dorsal border: ventral side of pectoralis major or ribs if difficult to
see it